AJMC June 23, 2022
Four experts from The US Oncology Network partnered with The American Journal of Managed Care® to present a webinar, “Beyond the OCM: How Are Commercial Payers & Employers Delivering Value-Based Cancer Care?”
Absent a late change of heart from CMS, the Oncology Care Model (OCM) will end June 30, 2022, without a replacement—ending one of Medicare’s most ambitious efforts to shift the mindset and the results of cancer care delivery.1 However, the end of the model does not mean the lessons of balue-based care will cease. The challenge, many providers say, will be figuring out how to keep what worked in the OCM without the support of the model’s Monthly Enhanced Oncology Services (MEOS) payments, which helped practices afford navigation...